Given the innumerable end uses for hemp, all hemp genetics are not created equal. How do we ensure low THC? How do we maintain quality control/consistency? What other phenotypes are important, e.g. CBD, protein, harvestability, drought tolerance? Where are farmers getting their seeds? How to genetics companies navigate IP?
Shonda Warner – Managing Partner, Chess Ag Full Harvest Partners
Josh Hendrix – Director of Hemp Production, CV Sciences
Trey Riddle – CEO, Sunstrand, LLC
Ron Conyea – Grower Representative, GenCanna Global
Moderator: Michael Bowman – Chief Strategist, First Crop, Inc. and Founding Board Chair, National Hemp Association